SB 249: AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE PROVISION OF INFORMATION ABOUT LYME DISEASE.
Latest action, June 13, 2018: Introduced and Assigned to Health, Children & Social Services Committee in Senate
Official summary
This Act, modeled on similar laws in Virginia and Maryland, requires a health care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health care provider if the patient continues to experience unexplained symptoms.